Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 578
Quick answer
578 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7208171
Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
granted -
US 7208161
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
granted -
US 7211445
Conjugation of biomolecules using diels-alder cycloaddition
granted -
US 7211432
Recombinant vector expressing multiple costimulatory molecules and uses thereof
granted -
US 7211192
Hybrid organic-inorganic adsorbents
granted -
US 7211402
Transcription factor coactivator protein, p/CIP
granted -
US 7211599
Use of etodolac to treat hyperplasia
granted -
US 7211255
Contraceptives based on SP22 and SP22 antibodies
granted -
US 7211252
Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
granted -
US 7214784
Protective antigens for the control of Ixodes species infestations
granted -
US 7214512
Genomic mammary Amyloid a sequence
granted -
US 7214687
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 7214366
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
granted -
US 7214391
Botanical extract compositions and process for preparing same
granted -
US 7214787
Recombinant vaccine against botulinum neurotoxin
granted -
US 7216041
Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket
granted -
US 7214495
Screening method
granted -
US 7214524
Marek's disease virus vaccine
granted -
US 7214690
Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
granted -
US 7214519
Screening method for identifying heme independent modulators of soluble guanylyl cyclase (sGC) activity using αβCys105 mutant sGC
granted -
US 7217719
Spiroazacyclic compounds as monoamine receptor modulators
granted -
US 7217785
Cysteine-containing peptides having antioxidant properties
granted -
US 7217812
Extraneous DNA sequence that facilitates hantavirus gene expression
granted -
US 7217427
Polymersomes and related encapsulating membranes
granted -
US 7217418
Multivalent dengue virus vaccine
granted -
US 7217795
Tumor suppressor designated TS10q23.3
granted -
US 7217811
Human gene critical to fertility
granted -
US 7217808
RFRP-3 and DNA thereof
granted -
US 7217739
Method for inducing cell death with carbonyl scavengers
granted -
US 7217738
β2-adrenergic receptor agonists
granted -
US 7217571
Gene therapy by small fragment homologous replacement
granted -
US 7217541
Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections
granted -
US 7220431
Methods and compositions for applying pharmacologic agents to the ear
granted -
US 7220739
Therapeutic application of pro-apoptotic benzodiazepines
granted -
US 7220582
Stem cells that transform to beating cardiomyocytes
granted -
US 7220419
Self-assembling recombinant papillomavirus capsid proteins
granted -
US 7220726
Antifungal pimaricin compositions and therapeutic methods employing same
granted -
US 7220852
Coronavirus isolated from humans
granted -
US 7220837
Modified vitamin K-dependent polypeptides
granted -
US 7220853
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
granted -
US 7220719
Modulation of endogenous gene expression in cells
granted -
US 7220745
Heterocyclic compounds useful to treat HCV
granted -
US 7220730
Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer
granted -
US 7220718
Oral treatment of hemophilia
granted -
US 7220421
Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
granted -
US 7220583
Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
granted -
US 7220558
Cartilage-derived morphogenetic proteins
granted -
US 7220328
Low-smoke gas generating low order pressure pulse compositions
granted
Frequently asked questions
How many pharma patents expire in 2027?
578 published patents in our USPTO index have expiration dates falling in calendar year 2027.